1. Prognosis in adult indolent systemic mastocytosis: A long-term study of the Spanish Network on Mastocytosis in a series of 145 patients 
Luis Escribano, MD, PhD, Iván Álvarez-Twose, MD, Laura Sánchez-Muñoz, MD, PhD, Andres Garcia-Montero, PhD, Rosa Núñez, MD, Julia Almeida, MD PhD, Maria Jara-Acevedo, MSc, Cristina Teodósio, MSc, Mónica García-Cosío, MD, PhD, Carmen Bellas, MD, PhD, Alberto Orfao, MD, PhD 
Journal of Allergy and Clinical Immunology 
Volume 124, Issue 3, Pages (September 2009)
DOI: /j.jaci
Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2. Fig 1
Progression-free survival (PFS) and overall survival (OS) in mastocytosis (n = 145). Panels A-C show PFS according to β2-microglobulin serum levels ( normal vs increased) and presence () vs absence () of D816V KIT-mutation in all hematopoietic lineages, respectively. Panels D-G show OS according to presence () vs absence () of an AHNMD, increased () vs normal () serum alkaline phosphatase and age at diagnosis >60 years () vs <60 years (), respectively.
Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci )
Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions